GRAIL
Detect cancer early, when it can be cured.
GRAIL is a healthcare company innovating to solve medicine’s most important challenges. Our team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it is more treatable and potentially curable. GRAIL's Galleri® test is a first-of-its-kind multi-cancer early detection (MCED) test that can detect a signal shared by more than 50 cancer types and predict the tissue type or organ associated with the signal to help healthcare providers determine next steps.
For Tasks:
Click tags to check more tools for each tasksFor Jobs:
Features
- Detects a signal shared by more than 50 cancer types
- Predicts the tissue type or organ associated with the signal
- Helps healthcare providers determine next steps
- Easy to use - just a simple blood draw
- Covered by Medicare and most major insurance plans
Advantages
- Can detect cancer at an early stage, when it is more treatable and potentially curable
- Can help to reduce the number of unnecessary biopsies and other invasive procedures
- Can provide peace of mind for those who are at high risk of developing cancer
- Can help to improve the quality of life for cancer patients and their families
- Can help to reduce the cost of cancer care
Disadvantages
- Can be expensive
- May not be covered by all insurance plans
- May not be able to detect all types of cancer
Frequently Asked Questions
-
Q:What is the Galleri® test?
A:The Galleri® test is a first-of-its-kind multi-cancer early detection (MCED) test that can detect a signal shared by more than 50 cancer types and predict the tissue type or organ associated with the signal to help healthcare providers determine next steps. -
Q:How does the Galleri® test work?
A:The Galleri® test analyzes DNA that has been shed by all cells, including cancer cells, into the bloodstream, looking for abnormal methylation patterns on those cell-free DNA fragments that may indicate the presence of cancer. -
Q:Who should get the Galleri® test?
A:The Galleri® test is recommended for adults who are at average risk of developing cancer, as well as those who are at high risk due to family history or other factors. -
Q:How much does the Galleri® test cost?
A:The Galleri® test costs $949. It is covered by Medicare and most major insurance plans. -
Q:Where can I get the Galleri® test?
A:The Galleri® test is available through healthcare providers and at select retail locations.
Alternative AI tools for GRAIL
Similar sites
GRAIL
GRAIL is a healthcare company innovating to solve medicine’s most important challenges. Our team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it is more treatable and potentially curable. GRAIL's Galleri® test is a first-of-its-kind multi-cancer early detection (MCED) test that can detect a signal shared by more than 50 cancer types and predict the tissue type or organ associated with the signal to help healthcare providers determine next steps.
Butterfly iQ3
Butterfly iQ3 is a handheld, whole-body ultrasound device that provides clear and detailed images for a variety of medical applications. It is the third-generation probe from Butterfly Network, and it features double the processing power and clearer images than its predecessors. Butterfly iQ3 is also equipped with real-time AI, which can help clinicians to identify and diagnose medical conditions more quickly and accurately. The device is lightweight and portable, making it easy to use in a variety of settings, including the clinic, the hospital, and the field. Butterfly iQ3 is a valuable tool for clinicians who want to improve the quality of care they provide to their patients.
Galleri
Galleri is a multi-cancer early detection test that uses a single blood draw to screen for over 50 types of cancer. It is recommended for adults aged 50 or older who are at an elevated risk for cancer. Galleri is not a diagnostic test and does not detect all cancers. A positive result requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.
Freenome
Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.
Cleerly
Cleerly is a digital healthcare company transforming the way clinicians approach the treatment of heart disease. Our clinically-proven, AI-based digital care platform works with coronary computed tomography angiography (CCTA) imaging to help clinicians precisely identify and define atherosclerosis earlier, so they can provide personalized, life-saving treatment plans for all patients throughout their care continuum. We measure atherosclerosis - plaque build-up in the heart's arteries - not indirect markers such as risk factors and symptoms of disease. Our AI-enabled digital care pathway offers simpler, faster, more accurate heart disease evaluation and reporting that's tailored to each stakeholder, improving overall clinical and financial outcomes.
Viz.ai
Viz.ai is an AI-powered care coordination platform that helps providers improve patient outcomes. The platform uses advanced algorithms to analyze medical imaging data and provide real-time insights and automated assessments to accelerate diagnosis and treatment. Viz.ai's solutions are used by hospitals and health systems across the country to improve care for patients with a variety of conditions, including stroke, heart disease, and cancer.
Abridge
Abridge is an enterprise-grade AI platform for clinical conversations that transforms patient-clinician conversations into structured clinical notes in real-time. It saves hours of time-consuming documentation per clinician every month, provides clinically accurate summaries and medical terms across specialties, recognizes and takes accurate notes across a wide range of languages, and creates complete, highly accurate, structured clinical note drafts. Abridge is integrated directly inside Epic, allowing clinicians to harness its power without leaving the platform. The application aims to return time to teams, clarity to patients, and efficiencies to healthcare systems, ultimately reducing burnout and improving overall healthcare experiences.
Linus Health
Linus Health is a next-generation digital cognitive assessment platform that enables earlier detection and intervention in brain health. It brings the power of AI to long-trusted cognitive tests, delivering rich insights and actionable clinical guidance. Linus Health's technology has been validated in over 20 published studies and is used by leading organizations to transform their approach to brain health.
Iterative Health
Iterative Health is a company that is dedicated to providing world-class GI care and treatment to patients around the world. They are on a mission to bring world-class care and treatment to patients around the world. Advances in machine learning and artificial intelligence are helping them create a complete GI ecosystem with the power to turn this vision into reality.
Microsure
Microsure is a company that develops microsurgical robots to help surgeons perform complex procedures with greater precision and dexterity. Their flagship product, MUSA, is a robot-assisted microsurgery platform that enables surgeons to operate on the smallest anatomical structures with high precision and enhanced dexterity. Microsure's mission is to leave no patient in need of microsurgery untreated.
MediSearch
MediSearch is an AI-powered application that provides direct science-based answers to medical questions. Users can filter their search queries and start with common questions before diving deeper into more complex medical inquiries. The application is designed to offer reliable information and insights on various health-related topics, serving as a valuable resource for individuals seeking accurate medical information. MediSearch emphasizes that it is not a substitute for consulting a medical professional and operates within the framework of its Terms of Use.
Limbic
Limbic is a clinical AI application designed for mental healthcare providers to save time, improve outcomes, and maximize impact. It offers a suite of tools developed by a team of therapists, physicians, and PhDs in computational psychiatry. Limbic is known for its evidence-based approach, safety focus, and commitment to patient care. The application leverages AI technology to enhance various aspects of the mental health pathway, from assessments to therapeutic content delivery. With a strong emphasis on patient safety and clinical accuracy, Limbic aims to support clinicians in meeting the rising demand for mental health services while improving patient outcomes and preventing burnout.
AskEllyn.ai
AskEllyn.ai is a supportive platform dedicated to providing knowledge, wisdom, and advice for individuals diagnosed with breast cancer. The website offers a range of resources, including a chatbot named AskEllyn, which serves as a non-medical AI companion to offer judgment-free support and empower users to self-advocate. AskEllyn is available in multiple languages and is provided free of charge through The Lyndall Project, a non-profit organization focused on enhancing the patient experience through AI-powered conversational care.
Vicarious Surgical System
Vicarious Surgical is a company that develops robotic surgical systems. Their system is designed to be minimally invasive, with a focus on abdominal access and visualization through a single port. The system is also designed to be mobile and nimble, with a patient cart that connects with the patient and a surgeon console where the surgeon sits to drive the robotic instruments and enhanced 3D high-definition camera inside the patient.
Recursion
Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.
fast.ai
fast.ai is a non-profit organization that provides free online courses and resources on deep learning and artificial intelligence. The organization was founded in 2016 by Jeremy Howard and Rachel Thomas, and has since grown to a community of over 100,000 learners from all over the world. fast.ai's mission is to make deep learning accessible to everyone, regardless of their background or experience. The organization's courses are taught by leading experts in the field, and are designed to be practical and hands-on. fast.ai also offers a variety of resources to help learners get started with deep learning, including a forum, a wiki, and a blog.
For similar tasks
Oatmeal Health
Oatmeal Health is an AI-powered platform that specializes in cancer screening and clinical trials. The platform seamlessly integrates cancer screenings into Community Health Centers, utilizing AI risk assessments, care navigation, and advanced diagnostic screenings to support patients and track outcomes. Oatmeal Health aims to improve patient health, lower the overall cost of cancer care, and generate revenue for healthcare centers through evidence-based care and value-based initiatives.
Freenome
Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.
Galleri
Galleri is a multi-cancer early detection test that uses a single blood draw to screen for over 50 types of cancer. It is recommended for adults aged 50 or older who are at an elevated risk for cancer. Galleri is not a diagnostic test and does not detect all cancers. A positive result requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.
GRAIL
GRAIL is a healthcare company innovating to solve medicine’s most important challenges. Our team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it is more treatable and potentially curable. GRAIL's Galleri® test is a first-of-its-kind multi-cancer early detection (MCED) test that can detect a signal shared by more than 50 cancer types and predict the tissue type or organ associated with the signal to help healthcare providers determine next steps.
Freenome
Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.
iCAD
iCAD is an AI-powered application designed for cancer detection, specifically focusing on breast cancer. The platform offers a suite of solutions including Detection, Density Assessment, and Risk Evaluation, all backed by science, clinical evidence, and proven patient outcomes. iCAD's AI-powered solutions aim to expose the hiding place of cancer, providing certainty and peace of mind, ultimately improving patient outcomes and saving more lives.
For similar jobs
FutureKid.ai
FutureKid.ai is an AI-powered application that allows users to generate pictures of their future kids using just one image of each parent. The application uses advanced AI algorithms to create realistic HD images that provide a glimpse into the user's future family. The process is automated, ensuring user privacy by deleting all data from servers within 24 hours. FutureKid.ai is a German-based company that values user privacy and offers a unique way to visualize potential future offspring.
Galleri
Galleri is a multi-cancer early detection test that uses a single blood draw to screen for over 50 types of cancer. It is recommended for adults aged 50 or older who are at an elevated risk for cancer. Galleri is not a diagnostic test and does not detect all cancers. A positive result requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.
GRAIL
GRAIL is a healthcare company innovating to solve medicine’s most important challenges. Our team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it is more treatable and potentially curable. GRAIL's Galleri® test is a first-of-its-kind multi-cancer early detection (MCED) test that can detect a signal shared by more than 50 cancer types and predict the tissue type or organ associated with the signal to help healthcare providers determine next steps.
SeeYourBabyAI
SeeYourBabyAI is an AI-powered platform that offers a unique service to predict the appearance of your future baby based on photos of you and your partner. By leveraging advanced AI technology, the platform generates realistic images of potential sons and daughters with a high level of accuracy. Users can upload their photos, receive multiple AI-generated baby photos, and share them with family and friends. The platform focuses on precision, respects ethnic backgrounds, ensures privacy through encryption, and provides high-resolution, realistic photos for a one-time payment. SeeYourBabyAI aims to provide users with a heartwarming and fun experience of visualizing their future children.
Mapmygenome
Mapmygenome is an AI-powered platform that offers DNA testing products for health, fitness, and beauty. It provides personalized insights based on genetic analysis to help individuals make informed decisions about their health, wellness, and lifestyle choices. With over 23 years of genomics experience and the latest sequencing technology, Mapmygenome aims to empower users to take proactive steps towards improving their overall well-being.
HappyMama
HappyMama is an AI-powered tool designed to provide instant answers to pregnancy-related questions. Users can interact with HappyMama by typing messages to start a conversation and seek guidance throughout their pregnancy journey. The tool aims to offer reliable information and support to expectant mothers, helping them navigate the various aspects of pregnancy with ease and confidence.
Painfinder
Painfinder.co is a website that provides resources and information related to pain management. The webpage seems to be generated by the domain owner using Sedo Domain Parking. It offers content on various aspects of pain relief, treatment options, and general information on managing different types of pain. Users can access articles, tips, and possibly links to external resources to help them better understand and cope with pain.
Synaptiq Learning
Synaptiq Learning is an AI-powered learning platform designed for medicine students to study efficiently and effectively. It utilizes cutting-edge algorithms to personalize review schedules through evidence-backed spaced repetition techniques. The platform offers features such as customizable study experiences, personal progress tracking, collaborative deck sharing, and controller support. With a focus on adapting to individual learning needs, Synaptiq Learning aims to help users study less and remember more in the field of medicine.
March Health
March is an AI-powered women's health and wellness solution that offers comprehensive care from initial diagnosis to holistic management for conditions like Endometriosis, PCOS, and Pelvic Pain. The platform provides personalized screenings, recommendations, health coaching, and virtual clinical care, empowering women to proactively manage their health. March leverages AI technology to offer accurate non-invasive diagnoses, personalized pain management strategies, and home-based care options. The application aims to revolutionize women's health by providing tailored support and empowering women to prioritize their well-being.
Ubie
Ubie is a medical AI application that offers a symptom checker and helps users find possible causes for their symptoms. Developed by doctors, Ubie's AI-powered system generates personalized reports on potential health issues based on a user's symptoms and personal information. The application aims to provide quick and accurate health information to users, guiding them on when to see a doctor, what might be causing their symptoms, and treatment information. Ubie values quality and safety, continuously improving its AI in collaboration with medical professionals worldwide.
AskEllyn.ai
AskEllyn.ai is a supportive platform dedicated to providing knowledge, wisdom, and advice for individuals diagnosed with breast cancer. The website offers a range of resources, including a chatbot named AskEllyn, which serves as a non-medical AI companion to offer judgment-free support and empower users to self-advocate. AskEllyn is available in multiple languages and is provided free of charge through The Lyndall Project, a non-profit organization focused on enhancing the patient experience through AI-powered conversational care.
Nursing School Selection Guide
The website provides detailed information for beginners on selecting a nursing school, including points to consider, advantages and disadvantages of attending school, and what to study at nursing schools. It covers topics such as the curriculum, practical skills, and the importance of selecting a school based on personal goals and desired qualifications. The site also discusses the availability of dormitories, the purpose of nursing education, and the importance of clarifying learning goals and qualifications when choosing a nursing school.
proudP
proudP is a mobile application designed to help individuals assess symptoms related to Benign Prostatic Hyperplasia (BPH) from the comfort of their homes. The app offers a simple and private urine flow test that can be conducted using just a smartphone. Users can track their symptoms, generate personalized reports, and share data with their healthcare providers for tailored treatments. proudP aims to empower users to take control of their urinary health by providing an affordable and convenient at-home testing solution.
CareOasis
CareOasis is a platform dedicated to empowering family caregivers by providing them with the necessary resources and support. The platform offers personalized assistance, professional training, and compensation to help caregivers deliver the best care possible while also getting paid. CareOasis simplifies the process for caregivers to check their eligibility, get enrolled and certified, and start receiving regular paychecks for the care they provide. The platform aims to ease the burden on family caregivers and ensure they have the tools and support needed to continue delivering high-quality care to their loved ones.
Leny.ai
Leny.ai is an AI-powered medical assistant designed to provide instant support to medical professionals and patients. It offers features such as differential diagnosis, treatment plan drafting, discharge instructions, referral letters, and lab value analysis. Leny.ai aims to streamline healthcare processes, save time, and provide reliable and accurate medical information. The platform is still in beta mode and continuously improving to offer more accurate responses. It is focused on data security and privacy, although not currently HIPAA compliant. Leny.ai is free of charge at present and plans to transition to a subscription-based model in the future.
Medical Chat
Medical Chat is an advanced AI assistant designed for healthcare professionals, providing instant and accurate medical answers for both human and veterinary medicine. Its capabilities include diagnosing medical conditions, generating differential diagnosis reports, creating patient-specific clinic plans, and offering comprehensive drug information. Medical Chat utilizes the latest LLM models, including ChatGPT 3.5 and 4.0, to deliver reliable and up-to-date medical knowledge. The platform also features a vast database of professional medical textbooks, veterinary books, and PubMed articles, ensuring evidence-based responses. With its HIPAA compliance and commitment to data privacy, Medical Chat empowers healthcare providers to enhance their diagnostic capabilities and improve patient outcomes.
Coverletter.app
Coverletter.app is an AI-powered tool that helps job seekers create personalized, professional cover letters. The tool uses advanced AI technology to analyze a user's resume and the job description to generate a custom-tailored cover letter that highlights the user's skills and experience. Coverletter.app also offers a range of features to help users stand out from the competition, including the ability to customize their cover letter, get feedback from AI, and access real-life examples.
SymptomChecker.io
SymptomChecker.io is an AI-powered medical symptom checker that allows users to describe their symptoms in their own words and receive non-reviewed AI-generated responses. It is important to note that this tool is not intended to offer medical advice, diagnosis, or treatment and should not be used as a substitute for professional medical advice. In the case of a medical emergency, please contact your physician or dial 911 immediately.
Mediscribe Pro
Mediscribe Pro is an AI-powered medical scribe and documentation tool designed for healthcare professionals. It utilizes advanced medical language models and artificial intelligence to generate medical dictations, transcriptions, and chart notes. Mediscribe Pro is HIPAA and PIPEDA compliant, ensuring the security and privacy of user data. The tool offers a range of features to streamline medical documentation, including a library of 100+ medical templates, voice-activated note-taking, and seamless integration with existing EMR systems. Mediscribe Pro is designed to reduce administrative burden, improve efficiency, and enhance patient care by allowing clinicians to spend more time with patients and focus on providing quality care.
Eczemaless
Eczemaless is an AI-powered eczema management app that helps users track and manage their condition. The app offers a variety of features, including eczema severity scoring, real-time weather alerts, food tracking, user-friendly graphs, and customized care routines. Eczemaless is available in five languages and has been downloaded over 15,000 times.
SOAPME.AI
SOAPME.AI is an AI-powered SAAS application that helps clinicians generate accurate and efficient SOAP notes from patient conversations. With its HIPAA-compliant technology, SOAPME ensures fast and secure note-taking, allowing clinicians to focus more on patient care and reduce administrative burden.
Butterfly iQ3
Butterfly iQ3 is a handheld, whole-body ultrasound device that provides clear and detailed images for a variety of medical applications. It is the third-generation probe from Butterfly Network, and it features double the processing power and clearer images than its predecessors. Butterfly iQ3 is also equipped with real-time AI, which can help clinicians to identify and diagnose medical conditions more quickly and accurately. The device is lightweight and portable, making it easy to use in a variety of settings, including the clinic, the hospital, and the field. Butterfly iQ3 is a valuable tool for clinicians who want to improve the quality of care they provide to their patients.
Accuray
Accuray Incorporated is a radiation oncology company that develops, manufactures, and sells radiation therapy systems and software for the treatment of cancer. Accuray's products are used by radiation oncologists to deliver precise and effective radiation therapy treatments to patients with a variety of cancers, including prostate cancer, breast cancer, lung cancer, and brain cancer. Accuray's mission is to expand the curative power of radiation therapy to improve as many lives as possible.
Cleerly
Cleerly is a digital healthcare company transforming the way clinicians approach the treatment of heart disease. Our clinically-proven, AI-based digital care platform works with coronary computed tomography angiography (CCTA) imaging to help clinicians precisely identify and define atherosclerosis earlier, so they can provide personalized, life-saving treatment plans for all patients throughout their care continuum. We measure atherosclerosis - plaque build-up in the heart's arteries - not indirect markers such as risk factors and symptoms of disease. Our AI-enabled digital care pathway offers simpler, faster, more accurate heart disease evaluation and reporting that's tailored to each stakeholder, improving overall clinical and financial outcomes.